Spread the love“`html In an age where technology is advancing at breakneck speed, understanding the impact of modern ...
Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...
To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.
Administration has repeatedly irked presumed allies on COVID vaccine policy, from its silence on reported 32 million ...
A comprehensive review by UBC reveals that mRNA vaccines, after billions of doses, remain safe and effective against diseases ...
Detailed price information for Rocket Lab Corp (RKLB-Q) from The Globe and Mail including charting and trades.
Moderna has unveiled its first in vivo CAR-T program. Building on other groups’ ex vivo CAR-T data, the company plans to start clinical development of an off-the-shelf autoimmune disease prospect, ...
During its research day, the firm discussed a cell therapy effort in lupus, dubbed "007," and an AI platform for gleaning ...
Jeff Coller, a pioneering RNA biologist, has spent the past year vehemently advocating for the lifesaving promise of research ...
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. A sign marks an entrance to a Moderna building in ...
You can listen to more articles from The Conversation, narrated by Noa, here. Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results